BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15951068)

  • 1. Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines.
    Patel JR
    Vaccine; 2005 Jul; 23(31):4054-61. PubMed ID: 15951068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
    Patel JR; Shilleto RW
    Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
    Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
    J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
    van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
    Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bovine herpesvirus-1 inactivated vaccine against abortion and stillbirth in pregnant heifers.
    Zimmerman AD; Buterbaugh RE; Herbert JM; Hass JM; Frank NE; Luempert Iii LG; Chase CC
    J Am Vet Med Assoc; 2007 Nov; 231(9):1386-9. PubMed ID: 17976001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle.
    Del Médico Zajac MP; Puntel M; Zamorano PI; Sadir AM; Romera SA
    Res Vet Sci; 2006 Dec; 81(3):327-34. PubMed ID: 16540133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of live bovine herpesvirus-1 vaccines.
    Patel JR
    Vet J; 2005 May; 169(3):404-16. PubMed ID: 15848783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological response in cattle immunized with inactivated oil and Algel adjuvant vaccines against infectious bovine rhinotracheitis.
    Kamaraj G; Rana SK; Srinivasan VA
    New Microbiol; 2009 Apr; 32(2):135-41. PubMed ID: 19579689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a BHV-1/BEFV bivalent vaccine against bovine herpesvirus type 1 infection in cattle.
    Chung YC; Shen HY; Cheng LT; Liu SS; Chu CY
    Res Vet Sci; 2016 Dec; 109():161-165. PubMed ID: 27892866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
    Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
    J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of aerosol, intranasal and intramuscular vaccination against selected bovine viral diseases.
    Mann DD; Buening GM; Thorne JG
    Cornell Vet; 1983 Oct; 73(4):375-9. PubMed ID: 6313292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of experimental subunit vaccines for infectious bovine rhinotracheitis.
    Lupton HW; Reed DE
    Am J Vet Res; 1980 Mar; 41(3):383-90. PubMed ID: 6245609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Sardonini Q; Cassai E; Lo DM; Rotola A; Angelini R
    Comp Immunol Microbiol Infect Dis; 2002 Jan; 25(1):29-41. PubMed ID: 11831745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
    Makoschey B; Beer M
    Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No vaccine interference between bovine coronavirus and bovine herpesvirus-1 in a randomized trial when coadministrating two intranasal modified-live viral vaccines to neonatal calves.
    Bolton MW; Nordstrom S; Hill K; Midla L; Rajamanikam K; Griebel PJ
    Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38457927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to infectious bovine rhinotracheitis virus (IBRV) following natural infection or vaccination by intranasally or parenterally administered vaccines.
    Todd JD
    Dev Biol Stand; 1975; 28():526-9. PubMed ID: 165128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvanticity of recombinant bovine interleukin-1 beta: influence on immunity, infection, and latency in a bovine herpesvirus-1 infection.
    Reddy DN; Reddy PG; Minocha HC; Fenwick BW; Baker PE; Davis WC; Blecha F
    Lymphokine Res; 1990; 9(3):295-307. PubMed ID: 2169009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid onset of protection against infectious bovine rhinotracheitis with a modified-live virus multivalent vaccine.
    Fairbanks KF; Campbell J; Chase CC
    Vet Ther; 2004; 5(1):17-25. PubMed ID: 15150726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.